DCR

metastatic/advanced OC (mOC) - 2nd line (L2) metastatic/advanced OC (mOC) - 2nd line (L2)

versus pegylated liposomal doxorubicin
avelumab alone vs. pegylated liposomal doxorubicin 1 1.0better0.35.0100 %